Advisory Committee Meetings 101: A Conversation with Tim Franson, MD

Following the news of the May 12th FDA Advisory Committee meeting planned for SRP-9001 (delandistrogene moxeparvovec), Sarepta’s investigational gene therapy for Duchenne muscular dystrophy, PPMD hosts an important discussion with FDA expert Tim Franson around what Advisory Committee Hearings are all about.